![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SLC39A11 |
Gene summary for SLC39A11 |
![]() |
Gene information | Species | Human | Gene symbol | SLC39A11 | Gene ID | 201266 |
Gene name | solute carrier family 39 member 11 | |
Gene Alias | C17orf26 | |
Cytomap | 17q24.3-q25.1 | |
Gene Type | protein-coding | GO ID | GO:0000041 | UniProtAcc | Q8N1S5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
201266 | SLC39A11 | HTA11_3410_2000001011 | Human | Colorectum | AD | 7.40e-04 | -4.12e-01 | 0.0155 |
201266 | SLC39A11 | HTA11_347_2000001011 | Human | Colorectum | AD | 3.10e-13 | 6.98e-01 | -0.1954 |
201266 | SLC39A11 | HTA11_2112_2000001011 | Human | Colorectum | SER | 2.79e-03 | 6.34e-01 | -0.2196 |
201266 | SLC39A11 | HTA11_5212_2000001011 | Human | Colorectum | AD | 4.17e-02 | -4.97e-01 | -0.2061 |
201266 | SLC39A11 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 2.42e-08 | 7.14e-01 | 0.281 |
201266 | SLC39A11 | A002-C-010 | Human | Colorectum | FAP | 4.37e-04 | -1.93e-01 | 0.242 |
201266 | SLC39A11 | A001-C-207 | Human | Colorectum | FAP | 3.46e-03 | -1.82e-01 | 0.1278 |
201266 | SLC39A11 | A015-C-203 | Human | Colorectum | FAP | 1.61e-23 | -4.56e-01 | -0.1294 |
201266 | SLC39A11 | A015-C-204 | Human | Colorectum | FAP | 5.97e-05 | -1.92e-01 | -0.0228 |
201266 | SLC39A11 | A014-C-040 | Human | Colorectum | FAP | 3.60e-05 | -4.98e-01 | -0.1184 |
201266 | SLC39A11 | A002-C-201 | Human | Colorectum | FAP | 3.33e-16 | -4.52e-01 | 0.0324 |
201266 | SLC39A11 | A002-C-203 | Human | Colorectum | FAP | 3.32e-02 | -1.78e-01 | 0.2786 |
201266 | SLC39A11 | A001-C-119 | Human | Colorectum | FAP | 3.59e-07 | -3.99e-01 | -0.1557 |
201266 | SLC39A11 | A001-C-108 | Human | Colorectum | FAP | 3.04e-13 | -3.29e-01 | -0.0272 |
201266 | SLC39A11 | A002-C-205 | Human | Colorectum | FAP | 6.72e-26 | -5.47e-01 | -0.1236 |
201266 | SLC39A11 | A001-C-104 | Human | Colorectum | FAP | 6.84e-03 | -2.42e-01 | 0.0184 |
201266 | SLC39A11 | A015-C-005 | Human | Colorectum | FAP | 3.77e-02 | -8.81e-02 | -0.0336 |
201266 | SLC39A11 | A015-C-006 | Human | Colorectum | FAP | 2.62e-16 | -3.63e-01 | -0.0994 |
201266 | SLC39A11 | A015-C-106 | Human | Colorectum | FAP | 1.69e-10 | -2.42e-01 | -0.0511 |
201266 | SLC39A11 | A002-C-114 | Human | Colorectum | FAP | 7.25e-21 | -5.36e-01 | -0.1561 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00000411 | Liver | HCC | transition metal ion transport | 59/7958 | 105/18723 | 3.18e-03 | 1.47e-02 | 59 |
GO:0000041 | Stomach | GC | transition metal ion transport | 15/1159 | 105/18723 | 2.01e-03 | 2.03e-02 | 15 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501261 | Stomach | CAG | Parkinson disease | 44/368 | 266/8465 | 7.32e-15 | 7.05e-13 | 5.65e-13 | 44 |
hsa0501061 | Stomach | CAG | Alzheimer disease | 38/368 | 384/8465 | 1.45e-06 | 2.10e-05 | 1.68e-05 | 38 |
hsa0501271 | Stomach | CAG | Parkinson disease | 44/368 | 266/8465 | 7.32e-15 | 7.05e-13 | 5.65e-13 | 44 |
hsa0501071 | Stomach | CAG | Alzheimer disease | 38/368 | 384/8465 | 1.45e-06 | 2.10e-05 | 1.68e-05 | 38 |
Page: 1 2 3 4 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SLC39A11 | SNV | Missense_Mutation | novel | c.467N>C | p.Gly156Ala | p.G156A | Q8N1S5 | protein_coding | tolerated(0.15) | possibly_damaging(0.542) | TCGA-A8-A079-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | 5-fluorouracil | SD |
SLC39A11 | insertion | Nonsense_Mutation | novel | c.854_855insATAAAGAATGAGTCGA | p.Leu286Ter | p.L286* | Q8N1S5 | protein_coding | TCGA-A8-A09B-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | 5-fluorouracil | SD | ||
SLC39A11 | SNV | Missense_Mutation | rs763797008 | c.727C>T | p.Pro243Ser | p.P243S | Q8N1S5 | protein_coding | deleterious(0.02) | probably_damaging(1) | TCGA-EK-A3GK-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
SLC39A11 | SNV | Missense_Mutation | c.808G>A | p.Gly270Ser | p.G270S | Q8N1S5 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-3715-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
SLC39A11 | SNV | Missense_Mutation | c.199G>A | p.Ala67Thr | p.A67T | Q8N1S5 | protein_coding | deleterious(0.04) | probably_damaging(0.951) | TCGA-AA-3966-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SLC39A11 | SNV | Missense_Mutation | c.832G>A | p.Val278Ile | p.V278I | Q8N1S5 | protein_coding | tolerated(0.44) | benign(0.026) | TCGA-AA-A01V-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
SLC39A11 | SNV | Missense_Mutation | c.583N>A | p.Ala195Thr | p.A195T | Q8N1S5 | protein_coding | tolerated(0.08) | benign(0.005) | TCGA-AD-5900-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
SLC39A11 | SNV | Missense_Mutation | rs201967760 | c.392C>T | p.Ala131Val | p.A131V | Q8N1S5 | protein_coding | tolerated(0.32) | benign(0.001) | TCGA-F4-6570-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SLC39A11 | SNV | Missense_Mutation | novel | c.628N>T | p.Leu210Phe | p.L210F | Q8N1S5 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SLC39A11 | SNV | Missense_Mutation | novel | c.110N>A | p.Arg37Lys | p.R37K | Q8N1S5 | protein_coding | tolerated(0.38) | benign(0.074) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |